Angelica sinensis: A Novel Adjunct to Prevent Doxorubicin‐Induced Chronic Cardiotoxicity
Open Access
- 25 October 2007
- journal article
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 101 (6) , 421-426
Abstract
Abstract: Doxorubicin is an anthracycline antibiotic agent used in the treatment of a variety of solid and haematopoietic tumours, but its use is limited by formation of metabolites that induce acute and chronic cardiac toxicities. Angelica sinensis has been widely used to treat cardiovascular and cerebrovascular diseases in China. In the present study, we used an in vivo mouse model to explore whether A. sinensis could protect against doxorubicin‐induced chronic cardiotoxicity. Male ICR mice were treated with distilled water or water extraction of A. sinensis (15 g/kg, orally) daily for 4 weeks, followed by saline or doxorubicin (15 mg/kg, intravenously) treatments weekly. Cardiotoxicity was assessed by electrocardiograph, antioxidant activity in cardiac tissues, serum levels of creatine kinase, aspartate aminotransferase (AST) and histopathological change in cardiac tissues. A cumulative dose of doxorubicin (60 mg/kg) caused animal death and myocardial injury characterized by increased QT interval and decreased heart rate in electrocardiograph, decrease of heart antioxidant activity, increase of serum AST, as well as myocardial lesions. Pre‐treatment with A. sinensis significantly reduced mortality and improved heart performance of the doxorubicin‐treated mice as evidenced from normalization of antioxidative activity and serum AST, preventing loss of myofibrils as well as improving arrhythmias and conduction abnormalities. Furthermore, the in vitro cytotoxic study showed that A. sinensis did not compromise the antitumour activity of doxorubicin. These results suggested that A. sinensis elicited a typical cardioprotective effect on doxorubicin‐related oxidative stress, and could be a novel adjunct in the combination with doxorubicin chemotherapy.Keywords
This publication has 23 references indexed in Scilit:
- Doxorubicin-Induced CardiomyopathyProgress in Cardiovascular Diseases, 2007
- Estrogenic activity of standardized extract of Angelica sinensisPhytotherapy Research, 2006
- Electrocardiographic and Biochemical Evidence for the Cardioprotective Effect of Vitamin E in Doxorubicin-Induced Acute Cardiotoxicity in RatsEuropean Journal of Pediatric Surgery, 2005
- Doxorubicin activates nuclear factor of activated T-lymphocytes and Fas ligand transcription: role of mitochondrial reactive oxygen species and calciumBiochemical Journal, 2005
- The Cardiotoxicology of Anthracycline Chemotherapeutics: TRANSLATING MOLECULAR MECHANISM INTO PREVENTATIVE MEDICINEMolecular Interventions, 2005
- Screening of Antioxidants from Medicinal Plants for Cardioprotective Effect against Doxorubicin ToxicityBasic & Clinical Pharmacology & Toxicology, 2005
- Antioxidant activities of some common ingredients of traditional chinese medicine, Angelica sinensis, Lycium barbarum and Poria cocosPhytotherapy Research, 2004
- Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and CardiotoxicityPharmacological Reviews, 2004
- Screening and analysis of biologically active compounds inAngelica sinensis by molecular biochromatographyChromatographia, 1999
- Prospective evaluation of cardiotoxicity during a six-hour doxorubicin infusion regimen in women with adenocarcinoma of the breastThe American Journal of Medicine, 1985